Skip to content

PATENTED INGREDIENT

Norwegian Cod Milt Extract (PDRN)

The supplier describes a water-soluble powder extracted from Norwegian cod milt and presents it as a PDRN ingredient for beauty-from-within development. Manufacturer identity, brand, PDRN content and patent details remain unconfirmed. The human study summary requires review of the full report.

Norwegian Cod Milt Extract (PDRN)

INGREDIENT PROFILE

What this ingredient is documented for

Origin
Norway (supplier stated; origin documents pending)
  • Marine origin: the supplier describes an extract from wild Atlantic cod milt sourced in Norway, for evaluation in beauty-from-within formulations.
  • PDRN positioning: the presentation focuses on polydeoxyribonucleotide (PDRN). Content, molecular-weight distribution and analytical methods require confirmation against manufacturer specifications and batch COAs.
  • Water-soluble powder: the supplier proposes beauty drinks, sachets, capsules, tablets and gummies. Solubility, flavour and processing stability require formulation testing.
  • Human study documentation pending: the presentation describes 33 women taking 100 mg of cod milt extract daily for four weeks. This study amount is neither a pure PDRN dose nor a finished-product dosage recommendation.

Origin and formulation development

The supplier describes an extract from wild Atlantic cod milt sourced in Norway and proposes drinks, sachets, capsules, tablets and gummies. Development should start with confirmation of species, origin, manufacturer, extract composition and carriers, followed by solubility, sensory, heat-processing and storage-stability assessment. Fish-origin allergen information and applicable labelling belong in the ingredient documentation. This is not a vegetarian ingredient.


Pages 10–12 describe an Intertek evaluation involving 33 women taking 100 mg daily for four weeks. The presentation does not include the full report, comparator details, statistical methods or a traceable report number. Only the study design is recorded at this stage; improvement percentages, absolute safety, cell regeneration and anti-inflammatory claims are not adopted as product promises. Studies of other PDRN sources, animals, topical use or injections do not directly establish oral human effects for this cod extract.

Source documentation

User-supplied restricted ingredient presentation: page 9 for origin, pages 10–12 for the human evaluation summary, page 13 for dosage-form concepts and page 15 for supplier feature statements. This record summarises supplier information and is not independent verification. The original presentation and internal study data are not intended as public attachments.

  1. AA025-0801 Cod Milt Extract PDRN Ingredient Presentation (restricted)

    Supplier information; manufacturer, specifications, COAs and complete human study report pending. Page 8 mouse data concern Porphyra-derived PDRN, not efficacy evidence for this cod extract.

FORMULATION

Discuss this ingredient with ACC

Bring this ingredient into a formula, documentation and sourcing conversation with the ACC team.